Have £1k to invest today? I’d buy these 2 FTSE 100 shares in an ISA in this stock market crash

first_imgSimply click below to discover how you can take advantage of this. I would like to receive emails from you about product information and offers from The Fool and its business partners. Each of these emails will provide a link to unsubscribe from future emails. More information about how The Fool collects, stores, and handles personal data is available in its Privacy Statement. Have £1k to invest today? I’d buy these 2 FTSE 100 shares in an ISA in this stock market crash Buying FTSE 100 shares after the index’s recent market crash could be a risky move in the short run. The stock market could experience a further downturn in the coming months as the financial impact of coronavirus becomes known.As such, buying companies with relatively stable track records of financial performance could be a shrewd move. They may provide lower risks than many of the index’s members during what is likely to be a period of lower growth for the world economy.5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…And if you click here we’ll show you something that could be key to unlocking 5G’s full potential…With that in mind, here are two companies that have previously offered defensive characteristics. Buying them now in an ISA for the long run could lead to impressive returns. And those returns could be less dependent on the performance of the wider economy.GSKPharmaceutical company GSK (LSE: GSK) could deliver relatively resilient financial performance over the medium term. Its recent quarterly update showed that it was able to produce revenue growth of 19%. This included a 44% rise in sales within its consumer healthcare division, as well as a 19% rise in vaccine sales.This rate of growth may not be maintained. As stock building was prevalent during the period, its divisions are likely to be less reliant on the wider economic outlook than for many of its FTSE 100 peers.As such, GSK was able to maintain its guidance for full-year earnings. It is also set to continue paying dividends. This could broaden its appeal to income investors at a time when many FTSE 100 companies are deciding to reduce their shareholder payouts. Its yield of 4.9% could prove to be highly attractive during what looks set to be a sustained period of low interest rates.In terms of its growth potential, the company’s planned split into two separate businesses could lead to improving financial prospects as they benefit from greater efficiency over the coming years.FTSE 100 tobacco company Imperial BrandsAnother FTSE 100 company that could offer a relatively defensive business model is Imperial Brands (LSE: IMB). Its recent half-year results highlighted its increased focus on tobacco markets, where it has been able to improve its market share. Tobacco sales could prove to be relatively robust over the coming months, with their potential for price increases likely to offset volume declines.Next-generation products have proved to be a disappointment for Imperial Brands in recent months. It reported a 43% decline in their revenue in the first six months of the year, and they continue to represent a modest portion of the company’s total revenue.However, with a likely shift in strategy under a new CEO and plans to reduce its debt level, the company could offer improving financial prospects. Its dividend yield of 10%+ suggests that it could offer a wide margin of safety at the present time. Renowned stock-picker Mark Rogers and his analyst team at The Motley Fool UK have named 6 shares that they believe UK investors should consider buying NOW.So if you’re looking for more stock ideas to try and best position your portfolio today, then it might be a good day for you. Because we’re offering a full 33% off your first year of membership to our flagship share-tipping service, backed by our ‘no quibbles’ 30-day subscription fee refund guarantee. Peter Stephens owns shares of GlaxoSmithKline and Imperial Brands. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Imperial Brands. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. “This Stock Could Be Like Buying Amazon in 1997” I’m sure you’ll agree that’s quite the statement from Motley Fool Co-Founder Tom Gardner.But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.What’s more, we firmly believe there’s still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.And right now, we’re giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.center_img Enter Your Email Address Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge! Peter Stephens | Friday, 5th June, 2020 | More on: GSK IMB See all posts by Peter Stephens Image source: Getty Images Our 6 ‘Best Buys Now’ Shareslast_img read more

Read More →